Related Links Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Basic Trial Information
Trial Description
     Summary
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Phase III Supportive care, Treatment Approved-not yet active 18 and over Other 2006-002948-28 KKS-73-05, NCT00444093

Trial Description

Summary

Therapy-associated diarrhea during radiation therapy of small pelvis (including enteritis as a result of radiation therapy and enteritis as a result of radiation- and chemotherapy) is a common problem in multimodal cancer therapy. We investigate the therapeutic effect of either loperamide or tinctura opii in therapy- associated diarrhea in patients who receive radiation therapy of the small pelvis with or without chemotherapy.

Eligibility Criteria

Inclusion Criteria:

• Age ≥ 18 years

• Patients who will undergo a percutaneous radiation therapy in the area of the small pelvis. This includes patients with following malignancies: rectal carcinoma, prostate carcinoma, endometrial carcinoma, cervix carcinoma.

• Diarrhea grade 1 and grade 2 (Classification NCI-CTCAE Version 3.0)

• ECOG-Grade 0-2

• Enlightenment and written declaration of consent to the participation.

Exclusion Criteria:

• Pregnant patients or patients in lactation period.

• Severe dysfunction of liver or kidneys

• Injury or illness of brain e.g. increased intracranial pressure, cerebral arteriosclerosis

• Epilepsy

• Hypersensitivity to components of loperamide or tincture of opium

• Ileus

• Toxic megacolon

• Pseudomembranous colitis/ antibiotic-associated colitis

• Diarrhea associated with fever and bloody stools

• Acute increase of colitis ulcerous or bacterial colitis caused by invasive pathogenes

• Severe respiratory dysfunction or severely limited lung function e.g. bronchial asthma, bronchitis

• Dysfunctional draining of biliary area, biliary colics.

• Concomitant or earlier addiction of alcohol or opiates

• Severe heart disease

• Pheochromocytoma

• Acute hepatic porphyria

• Cor pulmonale

• Morbus Addison

• Severe hypothyroidism

• Organisational problems or circumstances which prevent a complete collection of required data

• Artificial anus

• Participation in a clinical trial within the last 30 days before involvement

• Participation in an other clinical trial at the same time

Trial Contact Information

Trial Lead Organizations/Sponsors

Universitaetsklinikum Giessen und Marburg GmbH - Marburg

Michael Bieker, MD

Principal Investigator

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00444093
Information obtained from ClinicalTrials.gov on February 27, 2008